Justin Stebbing shared a post by Biorasi, on LinkedIn, adding the following:

“thanks for a lovely chat”

Quoting Biorasi’s post:

“’It’s really staggering to see those advances which have led to improvements in quality of life but massive improvements in quantity of life as well.’ – Justin Stebbing, Editor-in-Chief of Oncogene, previously the UK’s first NIHR (National Institute for Health and Care Research) Research Translational Professor of Oncology, Professor of Biomedical Sciences, Anglia Ruskin University, Cambridge.

Biorasi‘s Chris O’Brien welcomes Professor Justin Stebbing to the latest episode of the Few & Far Between podcast.

Find this new episode on your favorite streaming platform or visit here.”

Source: Justin Stebbing/LinkedIn and Biorasi/LinkedIn

Justin Stebbing is a visiting Professor of Cancer Medicine and Oncology at Imperial College, London and a Professor of Biomedical Sciences at Anglia Ruskin University (ARU), Cambridge. He was appointed the first NIHR oncology professor in 2011. He is editor-in-chief of Nature’s cancer journal Oncogene. Prof. Stebbing has published over 700 peer-reviewed papers in leading academic journals. He is a member of the American Society for Clinical Investigation, a fellow of the Royal College of Physicians, and the Royal College of Pathologists, and sits on many advisory boards. He is on the Editorial Board of OncoDaily.